Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone disease in primary hypercalciuria.

Sandro Giannini1, Martino Nobile, Stefania Sella

  • 1Department of Medical and Surgical Sciences, University of Padova, Italy. sandro.giannini@unipd.it

Critical Reviews in Clinical Laboratory Sciences
|July 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unsolved Issues in Managing CKD-Associated Osteoporosis: Myths, Facts, and Clinical Grey Zones.

Kidney360·2026
Same author

Prevalence, predictors, and clinical impact of vitamin D deficiency on 12-month outcomes in hip fracture patients.

Journal of endocrinological investigation·2026
Same author

Bone Marrow Edema in Rheumatic Diseases: Incidence, Diagnosis, and Therapeutic Implications. A Narrative Review.

La Clinica terapeutica·2026
Same author

Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.

European journal of endocrinology·2026
Same author

Under-recognized, under-referred: a multidisciplinary evaluation of fragility fracture management in the emergency setting.

Archives of osteoporosis·2026
Same author

The time has come for comprehensive geriatric assessment in internal medicine.

European journal of internal medicine·2026

Primary hypercalciuria (PH) is frequently linked to bone demineralization and fractures. Research suggests disturbed calcium transport and elevated cytokines contribute to bone loss in PH patients.

Area of Science:

  • Endocrinology
  • Nephrology
  • Bone Metabolism

Background:

  • Primary hypercalciuria (PH) is often associated with bone demineralization, particularly in patients with calcium nephrolithiasis.
  • Low bone density and increased fracture risk are common in PH patients, with low bone turnover being a frequent histomorphometric finding.

Purpose of the Study:

  • To explore the complex relationship between bone loss and primary hypercalciuria.
  • To investigate the role of various factors, including cytokines and intestinal calcium absorption, in the pathogenesis of bone disease in PH.

Main Methods:

  • Review of existing literature and clinical observations regarding bone density, calcium metabolism, and related factors in PH patients.
  • Analysis of proposed mechanisms involving bone resorbing-cytokines, dietary acid load, intestinal calcium transport, and renal phosphate handling.

Related Experiment Videos

Main Results:

  • Bone loss is a common comorbidity in PH, with fasting hypercalciuria potentially indicating primary bone metabolism alterations.
  • Elevated levels of cytokines (IL-1, IL-6, TNF-alpha) and increased intestinal calcium absorption are implicated in bone demineralization.
  • Renal factors, such as phosphate loss, may also contribute to bone loss in PH.

Conclusions:

  • Bone loss is highly prevalent in primary hypercalciuria patients.
  • While several contributing factors are identified, the precise mechanisms underlying bone disease in PH require further elucidation.